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ABSTRACT 
 
Douglas Allen Becker: The human health impacts of future changes in air quality and 
temperature in the United States 
(Under the direction of J. Jason West) 
 
 
Human emissions influence ozone concentrations, PM2.5 concentrations, and temperature 
levels, which are known to increase morbidity and mortality. Here we use the BenMap program 
to estimate the health impacts of modeled changes in air quality and temperature in the 
continental United States in 2025 relative to 2005. In a simulation containing changes in both 
anthropogenic emissions and meteorology, we estimate that ozone-related respiratory mortality 
decreases by 2,400 (90% CI 1,100-3,700) annually and all-cause mortality associated with PM2.5 
decreases by 26,000 (90% CI 19,000-32,000). In this same simulation, heat-related 
cardiovascular mortality increases by 31,000 (90% CI 18,000-44,000). Additionally, we find 
substantial decreases across all morbidity endpoints and significant geographical variation 
throughout all endpoints. Finally, the economic costs of these health impacts are estimated at $48 
billion per year. Our results suggest that emissions control schemes may provide substantial 
human health benefits, and mitigation and adaptation measures against heat-related impacts are 
needed.  
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CHAPTER 1: INTRODUCTION 
 
 
 Human activities including electricity generation, motorized transportation, construction, 
and manufacturing all rely on the combustion of fossil fuels. This combustion emits air pollutant 
precursors (Brauer et al. 2012). These air pollutant precursors undergo atmospheric reactions, 
leading to the creation of secondary air pollutants. The air pollutants of interest in this study are 
ozone and fine particulate matter, both of which influence air quality and contribute to climate 
change.  
 The fossil fuel combustion involved in many human activities also leads to the emission 
of greenhouse gases. Greenhouse gases (such as carbon dioxide, methane, and nitrous oxide) 
absorb radiation, increasing the temperature of the atmosphere and contributing to climate 
change.  
 Additionally, climate variability impacts air quality and temperature. Unlike climate 
change, climate variability represents change over short periods of time and does not indicate 
long-term climate trends. Significant year-to-year climate variations may exist while long-term 
averages may remain static. When considering data from short time periods, like the year-long 
samples used in this study, results may not be driven by climate change alone; climate variability 
is a potentially confounding cause.  
 Alterations in emissions levels, a changing climate system, and temporal climate 
variability all contribute to changes in temperature and air quality. Changes in temperature and 
air pollutant concentrations in turn drive changes in human morbidity and mortality.    
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Air Pollution 
 
 Ozone and PM2.5 have well-documented human health effects and are influenced 
significantly by anthropogenic emissions and climate change (Tagaris et al., 2009). Ozone, a 
powerful oxidant comprised of three oxygen atoms, is formed by a complex photochemical 
oxidation in the troposphere of carbon monoxide, methane, and volatile organic compounds 
(VOCs) via the hydroxyl radical (OH). This reaction requires the presence of reactive nitrogen 
oxide species (NOx) and solar energy (Jacob and Winner, 2009). Anthropogenic emissions 
contribute significantly to ozone formation.  
 Particulate matter is comprised of many compounds including sulfate, nitrate, and 
organic carbon, which are produced by the atmospheric oxidation of SO2, NOx, and VOCs, 
respectively. Sulfur dioxide, NOx, VOCs, and constituents of particulate matter are emitted by 
human activity. Forest fires, dust storms, and other natural events eject dust, salt, and other 
components into the atmosphere (Forster et al., 2001).  
 
Climate Change 
 
The Intergovernmental Panel on Climate Change (IPCC) estimates that the global 
average temperature has increased by 0.85 [0.65 to 1.06] degrees Celsius between the years 1880 
and 2012 and projects that global average temperatures will increase at an accelerating rate, 
enhancing temperatures by another 0.47 to 1.00 °C by 2035 (IPCC, 2013). In the United States 
alone in 2011, greenhouse gas emissions totaled 6,702 million metric tons of CO2 equivalent 
(EPA, 2012). 
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Air Pollution, Emissions, and Climate Change 
 
 As secondary pollutants produced by complex atmospheric reactions, ozone and 
particulate matter concentrations depend heavily on atmospheric conditions. Climate change 
affects air pollutant concentrations by altering meteorology, chemical reaction rates, temperature, 
precipitation, biogenic and natural emissions, deposition, and atmospheric circulation and 
ventilation (Weaver et al., 2009). Conversely, ozone and particulate matter are climate forcing 
agents (IPCC, 2007).  
 Climate change influences ozone concentrations by inducing higher temperatures, 
altering humidity and water vapor concentrations, and changing meteorological conditions 
(Weaver et al., 2009). Particulate matter is also sensitive to atmospheric water content; in areas 
with increasing precipitation rates, particulate matter will be scavenged out of the atmosphere 
more readily (Fiore et al., 2012). Climate change may alter natural aerosol emissions as well, in 
many cases augmenting the release of aerosols and particulate matter precursors (Lam et al., 
2011). The correlation between PM2.5 and meteorology is not as strong as for ozone, and no 
significant correlation has been found between PM2.5 and temperature (Wise and Comrie, 2005).  
Many studies have modeled future air quality and the influence of changes in emissions 
and climate on air quality. Global ozone concentrations are expected to decrease over the course 
of the century as a result of decreasing emissions levels, perhaps by as much as 8 ppb (IPCC, 
2013). Global particulate matter concentrations are expected to decrease by an average of 1 
μg/m3 as a result of declining emissions during the same time period (IPCC, 2013). However, 
areas with currently high pollutant levels will experience higher pollutant concentrations as a 
result of regional feedback mechanisms involving higher temperatures and altered atmospheric 
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chemistry (IPCC, 2007). In addition to climate change, inter-annual climate variability affects air 
pollutant concentrations (Bernard, 2001).  
 
Air Pollution and Human Health 
 
Ozone exposure causes or contributes to asthma exacerbation, respiratory disease, 
cardiovascular disease, hospital admissions, emergency room visits, acute and chronic 
respiratory symptoms, school absences, and premature mortality (Jerrett et al., 2009, Pope et al., 
2011). 
Particulate matter exposure causes or contributes to respiratory symptoms and disease, 
asthma exacerbation, chronic and acute bronchitis, cardiovascular disease, hospital admissions, 
and premature mortality (Lepuele et al., 2012, Krewski et al., 2009). 
   
Temperature and Human Health 
 
 Average surface temperatures are expected to increase due to global warming. Summers 
are projected to be longer and warmer than in previous years. The frequency and intensity of 
extreme heat events (heat waves) are also projected to increase under a changing climate system 
(Zanobetti and Schwarz, 2008). Elevated temperatures and heat waves occur frequently in cities 
due to the urban heat island effect, as impervious surfaces and heat-absorbing materials prevent 
the escape of heat back into the atmosphere, and this effect is amplified by global warming 
(Jackson et al., 2010).  
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 Rising temperatures endanger human health. A high correlation between heat and excess 
all-cause mortality has been observed (Harlan and Ruddell, 2011). There are 400-700 estimated 
deaths associated with high temperature annually in the United States (Luber et al., 2008). Other 
health effects of heat exposure include heat stroke, heat exhaustion, acute renal failure, 
cardiovascular disease, electrolyte imbalance, nephritic syndrome, and diabetes exacerbation. 
Extreme heat events can cause thousands of deaths in a short period of time, such as the 2003 
heat wave in France with its nearly 15,000 estimated deaths (Poumadere et al., 2005).   
 
Related Studies  
 
Research by the EPA using BenMap estimated the air pollution-related health impacts of 
2005 modeled air pollution as compared to a non-anthropogenic background in the United States 
(Fann et al., 2011). Their annual health impact estimates associated with PM2.5 include 130,000 
premature deaths, 180,000 nonfatal heart attacks, 30,000 respiratory hospital admissions, 
110,000 emergency room visits, and 18 million lost days of work. In regards to ozone health 
impacts, they estimate 4,700 premature deaths, 31,000 respiratory hospital admissions, 19,000 
emergency room visits, and 11 million school absences per year.  
 A study investigating the influence of climate change in the US from 2001 to 2050 on the 
health impacts caused by ozone and PM2.5 utilizing BenMap estimated 4,000 annual PM2.5-
related premature deaths and 300 annual premature deaths associated with ozone (Tagaris et al., 
2009). A follow up to this research found significant regional variation in climate change-
induced air pollution impacts as well as high sensitivity of pollutant concentrations to precursor 
emission levels (Tagaris et al. 2010). Post et al. incorporated seven modeling systems (based on 
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the A1, A2, and B1 IPCC emissions scenarios), five population projections, and three health 
impact functions in BenMap in order to elucidate the variation in ozone mortality estimates, and 
found a range of -600 to 2,500 annual deaths in the US associated with climate change-induced 
changes in ozone concentrations from 2000 to 2050 (Post et al., 2012).  
 Research using modeled temperature data performed in BenMap estimated heat-related 
premature mortality between the years 2000 and 2050 in the United States. Their results include 
annual estimates of 3,700-3,800 all-cause deaths, 3,500 cardiovascular deaths, and 21,000-
27,000 non-accidental deaths by 2050, relative to 2000 (Voorhees et al., 2011).  
 
Objective 
 
The objective of this study is to estimate the future morbidity and mortality attributable to 
ozone, PM2.5, and high temperature exposure in the continental United States. We use the single 
years 2005 and 2025 as an illustration of the influence of changing emissions and climate 
change, although inter-annual climate variability may play a larger role than climate change 
during our time period. 
 Air quality and temperature are inextricably linked and both impact human health. The 
combined impact of air pollution and heat may be larger than the sum of the impacts of each, 
indicating a synergy between the two factors. Urban dwellers are particularly vulnerable to the 
combined impact of air pollution and heat, as the heat island effect, existing health problems, and 
high population density exacerbate the problem.  
 The human health impacts and corresponding economic effects of air quality and 
temperature are rarely quantified in the same modeling simulation. Given the close relationship 
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between these two factors and the danger they impose on public health, air quality and 
temperature justify simultaneous investigation. In this study, we estimate and compare the 
magnitude of health impacts of air pollutants and heat in the same modeling simulation. We 
estimate the health effects of air pollution and temperature independently for lack of a clear 
epidemiological function that might account for interactions between these variables on health.  
Using different air quality scenarios, we also aim to distinguish the effects of changes in 
emissions and climate change in regard to the health impacts of air pollution. Additionally, we 
seek to illustrate the geographical distribution and regional heterogeneity of these health impact 
estimates throughout the continental United States. The final aspect of this study entails 
assigning financial value to the morbidity and mortality caused by ozone, PM2.5, and 
temperature.  
Our practical objective of producing these morbidity and mortality estimates, health 
impact maps, and economic valuations is to inform air quality managers, public health 
professionals, government officials, and other interested parties about the extent of the impacts 
of emissions and climate change on human health.  
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CHAPTER 2: METHODS 
 
 In this study, we estimate and map the morbidity and mortality associated with changes 
in three air quality scenarios and temperature between the years 2005 and 2025 in the continental 
United States using an environmental health impact assessment modeling program, BenMap. By 
using modeled air quality and temperature data sets from 2005 and 2025, we are able to 
incorporate precursor emissions data (from the National Emissions Inventory) and meteorology 
projections for the same years, giving a comprehensive picture of the interaction between 
emissions and climate change in determining the health impacts of air quality and temperature.  
 
BenMap  
 
The analyses for this project are conducted in the Community Edition Version 1.0.8 of 
the Environmental Benefits Mapping and Analysis Program (BenMap) developed by the United 
States Environmental Protection Agency (EPA, 2013).  The EPA has developed this program to 
evaluate air quality management policies by quantifying and mapping the health impacts 
associated with changes in air quality. BenMap calculates the morbidity and mortality resulting 
from changes in air quality, as well as the associated financial costs.  
To do this, BenMap uses a health impact function with the following variables: air 
pollution change, concentration-response function, incidence, and exposed population. BenMap 
also contains a geographical information processing system, which calculates health impacts at 
various grid cell resolutions. The health impact assessment process of BenMap is shown in 
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Figure 1. With these estimates, BenMap can then perform an economic valuation by multiplying 
the change in incidence by the value of a statistical life and other economic indicators.  
 
Figure 1. The health impact assessment process used by BenMap.   
 
 
 
 
Health Impact Functions 
 
 Health impact functions employed in air quality and temperature analyses are derived 
from epidemiology studies and provide the standard mathematical basis for conducting health 
impact assessments. The typical health impact function follows the basic formula:  
 
Δy= y0(eβ*Δx - 1)Pop 
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 where Δy is the change in morbidity or mortality, y0 is the baseline morbidity or mortality 
rate, β is the coefficient derived from the relative risk of the exposure, Δx is the change in 
pollutant concentration, and Pop is the exposed population.  
The BenMap program contains a robust database of health impact functions. These 
functions are derived from prominent air pollution epidemiology studies.  
We use the health impact studies found in the 2008 ozone Regulatory Impact Analysis 
(RIA), including premature mortality (with the exception of respiratory mortality), emergency 
room visits, hospital admissions, restricted activity days, and lost days of school (EPA, 2008). 
These studies were carefully chosen via a rigorous selection process by the EPA. Since the most 
recent ozone RIA (published in 2008), a new, influential study on ozone-related mortality has 
been conducted by Jerrett et al. using the American Cancer Society cohort (Jerrett et al., 2009). 
This seminal study has become the standard in ozone epidemiology, and has been used in many 
important air pollution mortality studies (Anenberg et al., 2010, Lim et al., 2013, Silva et al., 
2013). We use this study to estimate ozone respiratory mortality, which serves as an indicator of 
total ozone mortality in this study. Similarly, for our analysis of PM2.5, we rely on the health 
impact studies used in the 2012 PM2.5 RIA, including premature mortality, bronchitis, asthma, 
emergency room visits, hospital admissions, and lost days of school (EPA, 2012). A key study 
used in the PM RIA is that of Krewski, and that study was chosen as the basis of the mortality 
estimates in this research as well (Krewski et al., 2009).  
Health impact functions that correspond to the pollutant and temperature metrics found in 
Table 1 were chosen. Temperature health impact functions (Base and Ostra, 2008) were chosen 
from a proof-of-concept study which used BenMap to produce heat-related health impact 
estimates (Voorhees et al., 2011). One health impact function, beta coefficient, and age range 
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was selected for each health endpoint. The specifications of the health impact functions used in 
this study, including age groups, beta coefficients, and references can be found in Appendix A 
(ozone), Appendix B (PM2.5), and Appendix C (temperature).  
Table 1. The metric specifications of ozone, PM2.5, and temperature.  
Pollutant Metrics 
Pollutant Seasonal Metric Daily Metric 
Ozone 
Six month summer average 
(April-September) 
8-Hour daily maximum 
PM2.5 Annual average 24-Hour daily average 
Temperature 
Warm season average (May-
September)  
24-Hour daily average 
apparent (heat index) 
 
 
Air Pollutant Concentrations 
 
 Air quality modeled data, supplied by the University of North Carolina’s Institute 
for the Environment, were simulated using the Community Multi-scale Air Quality Model 
(CMAQ), developed by the EPA’s Atmospheric Science Modeling Division. These CMAQ 
simulations were conducted as part of a downscaling exercise using results from a global general 
circulation model (the Community Earth System Model).  Meteorology was downscaled to the 
continental US using the Weather Research and Forecasting (WRF) model and these 
meteorological simulations were used to drive CMAQ.  The emissions assumptions for these 
modeling exercises were derived from the RCP (Representative Concentration Pathway) 4.5 
scenarios established by the Intergovernmental Panel on Climate Change (Thomson et. al., 
2011). The air quality grid resolution of these modeled data for ozone and particulate matter is 
36km.  
The baseline scenario in these model runs was chosen to be 2002, the coldest year of the 
five year period of 2001-2005. The warmest year of the 2021 to 2025 period, 2024, was chosen 
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for future projections. By selecting the coldest year as the baseline and the warmest year as the 
control, the largest temperature and meteorological difference between the baseline and control 
is selected. We use the simulation years of 2002 and 2024 to represent the years 2005 and 2025. 
Although we aim to discern the influence of changes in emissions and climate, inter-annual 
climate variability also plays a role in the changes between 2005 and 2025, although this role is 
difficult to quantify.  
The current and future simulation years in this study were set at 2005 and 2025, 
respectively, due to limited availability of emissions data (Woody et al., 2011). The year 2005 
was selected as the current year as it coincides with a recent National Emissions Inventory (NEI) 
by the Environmental Protection Agency (EPA, 2007). The future year was set at 2025, as 
emissions for this year could be interpolated from the EPA’s projections of 2020 and 2030 
national emissions levels based on the 2005 NEI.  
These interpolations include both current and planned national emissions control 
programs, and show a decrease in emissions and pollutant concentrations between 2005 and 
2025. Using simulations from the year 2025 also allows for changes in both emissions and 
meteorology to be accounted for, whereas future years beyond 2025 or 2030 contain a high 
degree of uncertainty with regard to emissions projections. A complete description of these 
modeling choices can be found in Woody et al. (Woody et al., 2011) 
Emission levels and meteorology from the year 2005 served as the baseline, which was 
then compared against three different air quality scenarios. The specifications of the baseline and 
three scenarios are seen in Table 2. Scenario 1 was compared against the baseline in order to 
conduct the health impact assessment of air pollution changes from the interactive effect of 
anthropogenic emissions and climate change. We also compare the baseline to Scenario 2 and 
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Scenario 3 to discern the air pollution-related health impacts associated individually with climate 
change and emissions, respectively.  
 
Table 2. The specifications for the baseline and three air quality scenarios. 
Air Quality Scenarios 
Scenario Emissions Meteorology 
Baseline 2005 2005 
One 2025 2025 
Two 2005 2025 
Three 2025 2005 
 
 Due to the photochemical nature of the reaction that produces ozone, an eight-hour 
window is selected as the metric to reflect high ozone concentrations during the day. Another 
determining factor of ozone concentrations is seasonality. Ozone concentrations are highest 
during the summer, due to the higher amounts of solar radiation. The modeled ozone values in 
this study consist of the average of these daily 8 hour maximum values for every day in the warm 
season of April 1 through September 30. The epidemiology studies from which our health impact 
functions are derived use this 8-hour summer season metric. 
The chemical formation of particulate matter is not as sensitive to solar energy as is 
ozone. Particulate matter concentrations are generally more uniform throughout the day and 
across seasons than is ozone. For this reason, PM2.5 concentration values in this study are the 
simple annual averages of the baseline and control years. As with ozone, the metric we use 
corresponds with the metric used in our epidemiology-derived health impact functions.  
The domain average deltas for ozone in the time period of 2005 to 2025 are as follows: 
Scenario 1: -1.273 ppb; Scenario 2: +0.560 ppb; Scenario 3: -1.782 ppb. National average deltas 
of PM2.5 concentrations in the 2005 to 2025 period are: Scenario 1: -0.592 μg/m3; Scenario 2: -
0.019 μg/m3; Scenario 3: -0/572 μg/m3. Between 2005 and 2025, pollutant concentrations of 
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ozone follow a general pattern of increases in urban areas in the Northeast, Midwest, and 
southern California and decreases across much of the central part of the US. Maps showing the 
change in air pollutant concentrations for both ozone and particulate matter in all three scenarios 
can be found in Appendix D.  
Temperature Data 
 
 We use air temperature data modeled with the Weather Research and Forecasting Model 
(WRF). The WRF model is a powerful numerical weather prediction system relied on for 
weather forecasting on scales ranging from meters to thousands of kilometers. The modeled 
temperature data we use are from the same simulation used to drive CMAQ simulations of air 
quality.  
  To be consistent with previous temperature-related mortality estimates using BenMap, 
the twenty-four hourly apparent temperature values for each day were averaged to produce a 
daily mean for each day in the high temperature season of May 1 through September 30 
(Voorhees et al., 2011). (Apparent temperature is defined as the air temperature as perceived by 
the body as a combined effect of temperature and relative humidity.) Then, summer averages 
were calculated for both 2005 and 2025. The national average apparent temperature change 
during this time period is +1.29 degrees Kelvin. The map illustrating the change in apparent 
temperature between 2002 and 2024 can be seen in Appendix D.  
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Population Data Sets 
 
 BenMap contains population data from the 2010 United States Census and future 
population projections calculated by an economic forecasting model developed by Woods and 
Poole Economics, Inc. (Woods and Poole, 2013). We set population to the year 2025, which is 
projected to be 354 million by the Woods and Poole model. This amounts to a 19% increase in 
population during the study period of 2005 to 2025, as the US population in 2005 was 298 
million.   
 
Baseline Morbidity and Mortality Rates 
 
 The BenMap program contains cause-specific morbidity and mortality data at the county 
level. These data are provided by the Center for Disease Control’s Wide-ranging Online Data for 
Epidemiologic Research (CDC-WONDER) online database (CDC, 2006). For this study, 
baseline mortality incidence rates projected for the year 2025 by the CDC for the WONDER 
database were selected. Morbidity incidence rate projections do not exist in the BenMap 
database. In place of projections, we use baseline morbidity incidence rates from the years 2007 
and 2008, which are also included in the BenMap program and derived from the CDC 
WONDER database. Via a spatial distribution formula, BenMap aggregates these county-level 
baseline incidence rates to each grid cell.  
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Aggregation and Valuation 
 
 We aggregate the incidence and valuation at the national level. Economic valuation was 
performed using valuation formulas built into BenMap by the Environmental Protection Agency. 
This calculation uses the valuation functions and standard values used by the EPA in health 
impact and regulatory assessments. EPA standard values include the value of a statistical life, 
inflation, income growth projections, as well as consumer goods, medical cost, and wage indices. 
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CHAPTER 3: RESULTS 
 
 Here we estimate the change in morbidity and mortality between 2005 and 2025 in the 
US for eleven ozone-related endpoints, twenty endpoints associated with PM2.5, and two heat-
related endpoints. The large amount and variety of health endpoints analyzed in this study were 
chosen to evaluate the extensive impacts of changes in air pollution and high temperature.  
 Throughout this paper, individual morbidity and mortality estimates were chosen to 
represent health endpoint groups. Different mortality types are independent estimates and are not 
considered additive. For this reason, one mortality endpoint must be selected as the best estimate 
of total mortality. This applies to mortality estimates as well as the economic valuation of 
mortality. 
We select respiratory mortality to represent ozone-related mortality, as ozone was 
identified by Jerrett et al. to have a significant effect on respiratory mortality compared to other 
types of mortality (Jerrett et al., 2009). All-cause mortality was selected to approximate total 
mortality attributable PM2.5, as PM2.5 has been shown to have systemic effect on the body and 
thus exerts a substantial effect on all-cause mortality (Krewski et. al., 2009). Finally, 
cardiovascular mortality was chosen to represent total heat-related mortality, as heat has been 
documented to have a disproportionate impact on the cardiovascular system (Luber et al., 2008). 
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Section 1: Air Pollution Health Impact Assessment  
 
Ozone Estimates 
 
By comparing Scenario 1, which contains both 2025 emissions and climate change, to the 
baseline, we estimate 2,400 fewer cases of respiratory mortality, 4,100 fewer emergency room 
visits, 1,500 fewer respiratory hospital admissions, 3.1 million fewer restricted activity days, and 
2.3 fewer million lost days of school at the national level per year. Complete ozone-related 
mortality and morbidity results in the Scenario 1 comparison can be seen in Tables 3 and 6.  
Scenario 2 illustrates how climate change influences ozone morbidity and mortality. In 
this scenario, we estimate increases in the following endpoints:  respiratory mortality of 1,700 
cases, 3,000 emergency room visits, 1,100 respiratory hospital admissions, 2.1 million restricted 
activity days, and 1.7 million lost days of school. Tables 4 and 7 display the full range of 
estimates from the ozone Scenario 2 comparison. A key characteristic of Scenario 2 is that all 
ozone health endpoints increase, suggesting that climate change has a strong positive influence 
on ozone concentrations and thus on ozone-related mortality and morbidity.  
By comparing Scenario 3 (which simulates 2025 emissions while holding current 
meteorology constant) to the baseline, we calculate a decrease in respiratory mortality of 3,700, 
2,400 fewer respiratory hospital admissions, 4.8 million fewer restricted activity days, and 3.7 
million fewer lost days of school. Full estimates of ozone-related mortality and morbidity are 
found in Tables 5 and 8, respectively. Without the interactive influence of climate change, 
changes in ozone mortality and morbidity are significantly lower.   
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Table 3. The change in ozone mortality in 2025 relative to 2005 in the comparison of Scenario 1 to the baseline. 
Scenario 1 Ozone Mortality  
Health Endpoint Start Age End Age Point Estimate 5th Percentile 95th Percentile 
All Cause 0 99 -2,500 -1,800 -3,100 
Cardiopulmonary 0 99 -800 -380 -1,200 
  Non-Accidental 0 99 -540 -240 -840 
  Respiratory 30 99 -2,400 -1,100 -3,700 
 
Table 4. The change in ozone mortality in the Scenario 2 comparison. 
Scenario 2 Ozone Mortality  
Health Endpoint Start Age End Age Point Estimate 5th Percentile 95th Percentile 
All Cause 0 99 +1,700 +1,300 +2,200 
Cardiopulmonary 0 99 +560 +260 +850 
  Non-Accidental 0 99 +380 +170 +590 
  Respiratory 30 99 +1,700 +730 +2,600 
 
Table 5. Changes in ozone mortality in the Scenario 3 comparison.  
Scenario 3 Ozone Mortality  
Health Endpoint Start Age End Age Point Estimate 5th Percentile 95th Percentile 
All Cause 0 99 -3,900 -2,900 -4,900 
Cardiopulmonary 0 99 -1,300 -600 -1,900 
  Non-Accidental 0 99 -860 -380 -1,300 
  Respiratory 30 99 -3,700 -1,700 -5,800 
 
Table 6. The change in ozone morbidity in Scenario 1 relative to the baseline.  
Scenario 1 Ozone Morbidity  
Health Endpoint Start Age End Age Point Estimate 5th Percentile 95th Percentile 
Emergency Room 
Visits  Asthma 
0 99 -4,100 -1,800 -6,300 
Hospital Admissions  
All Respiratory 
0 1 -1,500 -800 -2,200 
Hospital Admissions  
Chronic Lung 
Disease 
65 99 -1,100 +40 -2,200 
Hospital Admissions  
Chronic Lung 
Disease (less 
Asthma) 
65 99 -1,500 -580 -2,500 
Hospital Admissions  
Pneumonia 
65 99 -1,900 -430 -3,300 
Minor Restricted 
Activity Days 
18 64 -3,100,000 -1,600,000 -4,600,000 
School Loss Days  
All Cause 
5 17 -2,300,000 -100,000 -4,400,000 
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Table 7. Changes in ozone morbidity in Scenario 2 compared to the baseline.  
Scenario 2 Ozone Morbidity  
Health Endpoint Start Age End Age Point Estimate 5th Percentile 95th Percentile 
Emergency Room 
Visits  Asthma 
0 99 +3,000 +1,300 +4,600 
Hospital Admissions  
All Respiratory 
0 1 +1,100 +560 +1,600 
Hospital Admissions  
Chronic Lung 
Disease 
65 99 +900 -40 +1,800 
Hospital Admissions  
Chronic Lung 
Disease (less 
Asthma) 
65 99 +1,300 +480 +2,100 
Hospital Admissions  
Pneumonia 
65 99 +1,400 +330 +2,600 
Minor Restricted 
Activity Days 
18 64 +2,100,000 +1,100,000 +3,200,000 
School Loss Days  
All Cause 
5 17 +1,700,000 +100,000 +3,300,000 
 
 
 
 
Table 8. The change in ozone morbidity in the Scenario 3 comparison.  
Scenario 3 Ozone Morbidity  
Health Endpoint Start Age End Age Point Estimate 5th Percentile 95th Percentile 
Emergency Room 
Visits  Asthma 
0 99 -6,600 -3,000 -10,200 
Hospital Admissions  
All Respiratory 
0 1 -2,400 -1,260 -3,500 
Hospital Admissions  
Chronic Lung 
Disease 
65 99 -1,800 +70 -3,600 
Hospital Admissions  
Chronic Lung 
Disease (less 
Asthma) 
65 99 -2,600 -980 -4,200 
Hospital Admissions  
Pneumonia 
65 99 -3,100 -700 -5,400 
Minor Restricted 
Activity Days 
18 64 -4,900,000 -2,500,000 -7,200,000 
School Loss Days  
All Cause 
5 17 -3,700,000 -200,000 -7,100,000 
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Geographical Distribution of Ozone Health Impacts 
 
The changes in ozone concentrations exhibit significant geographical variation, as can be 
seen in Appendix D. This pattern is reflected in the health impact maps. Ozone concentrations 
rise significantly in some areas and fall in many others, with this pattern varying significantly by 
scenario.  
In the scenario including both emissions and climate change projections, regions 
exhibiting ozone concentration decreases include the East Coast, Midwest, and the Southwest 
and California, whereas ozone levels are projected to increase across much of the central part of 
the nation. For these reasons, we estimate ozone-related health impacts to decrease at the 
national level between 2005 and 2025.  
In the Scenario 1 ozone analysis, decreases in ozone-related mortality are most prevalent 
in highly populated regions near the US coasts, as shown in Figure 2. Southern California and 
Arizona experience the largest reductions of morbidity and mortality.  Eastern metropolitan 
areas, including Boston, New York, Atlanta, and Raleigh also stand out as areas with large 
downturns in ozone concentrations in Scenario 1. Maps of other health endpoints in Scenario 1 
can be found in Appendix E.  
Figure 2 illustrates the ozone Scenario 2 analysis. In Scenario 2, ozone-related mortality 
rises throughout much of the country, with the largest increases in cities in the Eastern half of the 
nation. The analysis of ozone in Scenario 3 shows a pattern similar to that of Scenario 1, with 
urban centers and coastal regions experiencing large reductions in mortality (Figure 3). 
Additional health endpoint examples can be seen in Appendix E.  
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Figure 2. The decrease in respiratory mortality attributable to ozone in Scenario 1, shown at the county level. Positive values 
indicate falling mortality rates; negative values are associated with increasing mortality.  
. 
 
Figure 3. The change in ozone-related respiratory mortality in Scenario 2. The negative values throughout much of the country, 
which indicate rising mortality between 2005 and 2025, reflects the rising ozone concentrations under a climate change-only 
simulation.  
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Figure 3. Trends in respiratory mortality due to ozone exposure in Scenario 3. 
 
 
 
Particulate Matter Estimates 
In the comparison of Scenario 1 with the baseline, we estimate 26,000 fewer cases of all-
cause mortality, 8 million fewer instances of exacerbated asthma cough, 10,000 fewer 
cardiovascular hospital admissions, 670,000 fewer occurrences of upper respiratory symptoms, 
35,000 fewer cases of acute bronchitis, 18 million fewer restricted activity days, and 3.1 million 
fewer lost days of work per year. Estimates for all health endpoints can be seen in Tables 9 and 
12.  
From the PM2.5 Scenario 2 comparison, our results show the following reductions: all-
cause mortality at 350, 140,000 cases of exacerbated asthma, 170 cardiovascular hospital 
admissions, 380 cases of chronic bronchitis, and 70,000 lost days of work. All endpoint estimates 
related to this scenario comparison can be found in tables 10 and 13. The results of this 
comparison represent the individual influence of climate change on PM2.5-related morbidity and 
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mortality. Estimates from Scenario 2 are significantly lower than those of Scenario 1, suggesting 
that the health impacts associated with PM2.5 are much less sensitive to climate change than to 
emissions levels.  
The Scenario 3 comparison yields very similar health impact reductions to those of 
Scenario 1. In Scenario 3, we estimate 25,000 fewer cases of all-cause mortality, 8.0 million 
fewer exacerbated asthma cases, 10,000 fewer cardiovascular hospital admissions, 17,000 fewer 
chronic bronchitis cases, and 3.0 fewer million lost days of work. Tables 11 and 14 display all 
mortality and morbidity endpoint estimates. It is noteworthy that these estimates so closely 
approximate those of the Scenario 1 analysis, as this demonstrates that PM2.5-related health 
impacts are heavily moderated by precursor emissions.   
Table 9. Changes in PM2.5-related mortality in Scenario 1 compared to the baseline. 
Scenario 1 PM2.5 Mortality  
Health Endpoint Start Age End Age Point Estimate 5th Percentile 95th Percentile 
All Cause 30 99 -26,000 -19,000 -32,000 
Ischemic Heart 
Disease 
30 99 -17,000 -15,000 -20,000 
Lung Cancer 30 99 -4,100 -2,200 -6,000 
 
Table 10. The change in mortality associated with PM2.5 in Scenario 2 relative to the baseline.  
Scenario 2 PM2.5 Mortality  
Health Endpoint Start Age End Age Point Estimate 5th Percentile 95th Percentile 
All Cause 30 99 -350 -260 -450 
Ischemic Heart 
Disease 
30 99 -340 -290 -390 
Lung Cancer 30 99 -30 -20 -40 
 
Table 11. The change in mortality of the Scenario 3 attributable to PM2.5.  
Scenario 3 PM2.5 Mortality  
Health Endpoint Start Age End Age Point Estimate 5th Percentile 95th Percentile 
All Cause 30 99 -25,000 -18,000 -32,000 
Ischemic Heart 
Disease 
30 99 
-17,000 
-15,000 
-20,000 
Lung Cancer 30 99 -4,100 -2,200 -6,000 
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Table 12. The morbidity associated with particulate matter exposure in Scenario 1 relative to the baseline.   
Scenario 1 PM2.5 Morbidity  
Health Endpoint Start Age End Age Point Estimate 5th Percentile 95th Percentile 
Acute Bronchitis 8 12 -36,000 +1,300 -70,000 
Acute Myocardial 
Infarction  Nonfatal 
0 99 -2,800 -1,600 -4,000 
Asthma Exacerbation  
Cough 
18 64 -8,100,000 -1,200,000 -15,000,000 
Asthma Exacerbation  
Shortness of Breath 
6 18 -610,000 -87,000 -1,100,000 
Asthma Exacerbation  
Wheeze 
6 18 -970,000 -310,000 -1,600,000 
Chronic Bronchitis 6 18 -17,000 -3,100 -30,000 
Emergency Room 
Visits  Asthma 
27 99 -17,000 -6,500 -27,000 
Hospital Admissions  
All Cardiovascular 
(less Myocardial 
Infarctions) 
0 99 -10,000 -7,700 -13,000 
Hospital Admissions  
All Respiratory 
65 99 -8,100 -5,200 -11,000 
Hospital Admissions    
Congestive Heart 
Failure 
65 99 -5,500 -1,700 -9,200 
Hospital Admissions  
Dysrhythmia 
0 17 -1,500 +2,600 -5,600 
Hospital Admissions    
Ischemic Heart 
Disease (less 
Myocardial 
Infarctions) 
65 99 -2,000 +650 -4,600 
Hospital Admissions    
Pneumonia 
18 64 -5,600 -1,800 -9,400 
Lower Respiratory 
Symptoms 
65 99 -460,000 -220,000 -690,000 
Minor Restricted 
Activity Days 
7 14 -18,000,000 -15,000,000 -21,000,000 
Upper Respiratory 
Symptoms 
9 11 -670,000 -210,000 -1,100,000 
Work Loss Days 18 64 -3,100,000 -2,660,000 -3,400,000 
 
Table 13. Particulate matter morbidity incidence in Scenario 2 relative to the baseline.  
Scenario 2 PM2.5 Morbidity 
Health Endpoint Start Age End Age Point Estimate 5th Percentile 95th Percentile 
Acute Bronchitis 8 12 -600 +20 -1,100 
Acute Myocardial 
Infarction  Nonfatal 
0 99 -50 -30 -60 
Asthma Exacerbation  
Cough 
18 64 -140,000 -23,000 -260,000 
Asthma Exacerbation  
Shortness of Breath 
6 18 -11,000 -1,600 -21,000 
Asthma Exacerbation  
Wheeze 
6 18 -18,000 -5,700 -30,000 
Chronic Bronchitis 6 18 -380 -70 -660 
Emergency Room 
Visits  Asthma 
27 99 -590 -220 -940 
Hospital Admissions  
All Cardiovascular 
0 99 -170 -130 -210 
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(less Myocardial 
Infarctions) 
Hospital Admissions  
All Respiratory 
65 99 -100 -60 -130 
Hospital Admissions    
Congestive Heart 
Failure 
65 99 -100 -30 -170 
Hospital Admissions  
Dysrhythmia 
0 17 -30 +50 -100 
Hospital Admissions    
Ischemic Heart 
Disease (less 
Myocardial 
Infarctions) 
65 99 -20 +10 -50 
Hospital Admissions    
Pneumonia 
18 64 -50 -20 -80 
Lower Respiratory 
Symptoms 
65 99 -7,800 -3,900 -11,000 
Minor Restricted 
Activity Days 
7 14 -410,000 -350,000 -470,000 
Upper Respiratory 
Symptoms 
9 11 -12,000 -3,700 -20,000 
Work Loss Days 18 64 -70,000 -61,000 -79,000 
 
 
 
Table 14. Particulate matter morbidity in the Scenario 3-baseline comparison.  
Scenario 3 PM2.5 Morbidity  
Health Endpoint Start Age End Age Point Estimate 5th Percentile 95th Percentile 
Acute Bronchitis 8 12 -35,000 +1,300 -70,000 
Acute Myocardial 
Infarction  Nonfatal 
0 99 -2,800 -1,600 -3,900 
Asthma Exacerbation  
Cough 
18 64 -8,000,000 -1,200,000 -15,000,000 
Asthma Exacerbation  
Shortness of Breath 
6 18 -600,000 -86,000 -1,100,000 
Asthma Exacerbation  
Wheeze 
6 18 -960,000 -300,000 -1,600,000 
Chronic Bronchitis 6 18 -17,000 -3,100 -30,000 
Emergency Room 
Visits  Asthma 
27 99 -17,000 -6,400 -27,000 
Hospital Admissions  
All Cardiovascular 
(less Myocardial 
Infarctions) 
0 99 -10,000 -7,600 -13,000 
Hospital Admissions  
All Respiratory 
65 99 -8,000 -5,200 -11,000 
Hospital Admissions    
Congestive Heart 
Failure 
65 99 -5,400 -1,700 -9,100 
Hospital Admissions  
Dysrhythmia 
0 17 -1,500 +2,600 -5,500 
Hospital Admissions    
Ischemic Heart 
Disease (less 
Myocardial 
Infarctions) 
65 99 -2,000 +700 -4,600 
Hospital Admissions    
Pneumonia 
18 64 -5,500 -1,700 -9,300 
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Lower Respiratory 
Symptoms 
65 99 -450,000 -220,000 -680,000 
Minor Restricted 
Activity Days 
7 14 -18,000,000 -15,000,000 -20,000,000 
Upper Respiratory 
Symptoms 
9 11 -660,000 -210,000 -1,100,000 
Work Loss Days 18 64 -3,000,000 -2,600,000 -3,400,000 
 
 
Geographical Distribution of PM2.5 Health Impacts  
 
In Scenario 1, the decreases in PM2.5-related health impacts are concentrated around 
highly populated urban areas such as Chicago; Atlanta; Los Angeles; Washington, D.C.; 
Baltimore; and New York City. An example of this is seen in Figure 4. Densely populated areas 
are estimated to have larger improvements in air quality and thus higher reductions of mortality 
and morbidity rates than surrounding rural areas. Maps of other examples of PM2.5-related health 
endpoints can be found in Appendix F.  
As seen in Tables 10 and 13, the levels of PM2.5 impacts in Scenario 2 differ from those 
in Scenarios 1 and 3. In many areas of the country, such as the Southeast and Southwest, 
morbidity and mortality actually increases slightly in Scenario 2 (Figure 5.) Without emissions 
changes, changes in climate cause higher rates of PM2.5-related illness and death in some regions 
of the country. At the national level, however, mortality and morbidity fall in Scenario 2.  
The map of mortality for PM2.5 in Scenario 3 is very similar in appearance to that of 
Scenario 1, as seen in Figure 6. With meteorological conditions held constant, changes in 
emission levels between 2005 and 2025 lead to substantially lower morbidity and mortality 
levels in eastern and southern states, as well as the Southwest. As in Scenario 1, the largest 
reductions in morbidity and mortality occur in cities, including Atlanta, Houston, Raleigh, 
Baltimore, New York, Pittsburgh, Chicago, and Los Angeles. 
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Figure 4. Changes in PM2.5-related all-cause mortality at the county level in Scenario 1. The largest decreases in mortality are 
found in urban areas, especially in the Northeast.  
 
 
 
Figure 5. The trends of PM2.5-related all-cause mortality from Scenario 2 at the county level. .  
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Figure 6. The changes in all-cause mortality attributable to PM2.5 exposure in Scenario 3.  
 
 
 
Influence of Emissions and Climate Change on Health Impacts 
  
 Here, the interaction of emissions and climate change, as well as the individual influence 
of each factor, is discerned by comparing the results of the three scenarios. Due to the 
nonlinearities between emissions and climate change, the scenario containing both climate 
change and emissions (Scenario 1) cannot be achieved simply by combining the climate change 
of Scenario 2 with the emissions of Scenario 3, although summing Scenarios 2 and 3 provide a 
close approximation of Scenario 1.  Scenario 1 represents the combined and interactive effect of 
emissions and climate change on the health impacts of air pollution.  
In the context of ozone health impacts, the three scenarios exhibit significant variability. 
Figure 7 illustrates the discrepancy between the health impacts in the three ozone scenarios. 
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Under the “climate change only” scenario (Scenario 2), an increase in ozone-related mortality is 
estimated, suggesting that climate change exacerbates ozone concentrations. Without the effect 
of climate change, changing emissions levels would lead to substantially lower mortality rates. 
The large variation in the three-scenario comparison demonstrates the high sensitivity of ozone 
concentrations to a changing climate system and supports the importance of limiting emissions 
of ozone precursors and greenhouse gases in concert.  
 The estimates of PM2.5 health impacts demonstrate the large influence of emissions as 
compared to climate change (Figure 8).  For example, in Scenario 2 relative to the baseline, all-
cause mortality attributable to PM2.5 exposure is -350, as compared to -26,000 in the Scenario 1 
comparison. All-cause mortality levels in Scenario 3 (-25,000), however, are almost identical to 
those of Scenario 1 (-26,000). This pattern emerges across all health endpoint estimates 
associated with PM2.5 exposure. These results suggest that the concentrations and health impacts 
of PM2.5 are determined mostly by changes in emissions, and display low sensitivity to climate 
change.  
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Figure 7. The ozone respiratory mortality for the three different scenarios relative to the baseline.  
  
 
Figure 8. The all-cause mortality attributable to PM2.5 is shown in this figure. The marked difference between Scenario 2 and the 
other two scenarios illustrates the substantial influence of emissions on PM2.5 concentrations. 
  
 
 
 
 
 
 
 
 
 
Scenario 1 Scenario 2 Scenario 3
Ozone Respiratory Mortality -2,400 1,700 -3,700
-4,000
-3,000
-2,000
-1,000
0
1,000
2,000
Ozone Respiratory Mortality
Scenario 1 Scenario 2 Scenario 3
PM2.5 All-Cause Mortality -26,000 -350 -25,000
-30,000
-25,000
-20,000
-15,000
-10,000
-5,000
0
PM2.5 All-Cause Mortality
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Section 2: Air Pollution Economic Valuation 
 
 We use BenMap to calculate the economic impact associated with each health endpoint 
in Scenarios 1, 2, and 3. For ozone health endpoints in Scenario 1, we estimate savings of $6 
billion from respiratory mortality annually, $30 million in hospital admissions, $77 million from 
lost days of school, and $74 million lost in restricted activity days. All ozone-related economic 
valuation estimates are seen in Table 15.  
 In the PM2.5 valuation for Scenario 1, we find cost reductions in the following endpoints: 
$140 billion attributable to all-cause mortality, $1.5 billion associated with asthma, $800 million 
in hospital admissions, $130 million in respiratory symptoms, and $1.3 billion from restricted 
activity days and lost days of work. Table 16 lists all the economic values associated with PM2.5 
across all three Scenarios.  
 
Table 15. The annual economic value of the health impacts due to ozone exposure in the three scenarios.  
Ozone Valuation 
Mortality 
 Scenario 1 Scenario 2 Scenario 3 
Endpoint Incidence Value ($ billions) Incidence 
Value ($ 
billions) 
Incidence Value ($ billions) 
All Cause -2,500 -6.5 +1,700 +4.6 -3,900 -10 
Cardiopulm
onary -800 
-2.1 +560 +1.5 
-1,300 
-3.3 
Non-
accidental -540 
-1.4 +380 +1.0 
-860 
-2.3 
Respiratory -2,400 -6.2 +1,700 +4.4 -3,700 -9.8 
Morbidity 
 Scenario 1 Scenario 2 Scenario 3 
Endpoint Incidence 
Value ($ 
millions) 
Incidence 
Value ($ 
millions) 
Incidence Value ($ millions) 
Emergency 
Room 
Visits, 
Asthma 
-4,100 -0.37 +3,000 +0.27 -6,600 -0.59 
Hospital 
Admissions, 
All 
Respiratory 
-1,500 -8.8 +1,100 +6.2 -2,400 -14 
Hospital 
Admissions, 
Chronic 
Lung 
Disease 
-1,100 -4.9 +900 +3.9 -1,800 -8.1 
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Hospital 
Admissions, 
Chronic 
Lung 
Disease (less 
Asthma) 
-1,500 -6.9 +1,300 +5.7 -2,600 -12 
Hospital 
Admissions, 
Pneumonia 
-1,900 -10 +1,400 +7.8 -3,100 -17 
Minor 
Restricted 
Activity 
Days 
-3,100,000 -74 +2,100,000 +51 -4,900,000 -120 
School Loss 
Days 
-2,300,000 -78 +1,700,000 +57 -3,700,000 -124 
 
Table 16. The annual economic value of the health impacts associated with PM2.5 in the three scenarios. 
PM2.5 Valuation 
Mortality 
 Scenario 1 Scenario 2 Scenario 3 
Endpoint Incidence Value ($ billions) Incidence 
Value ($ 
billions)  
Incidence Value ($ billions) 
All Cause -26,000 -140 -350 -1.9 -25,000 -139 
Ischemic Heart 
Disease 
-17,000 -96 -340 -1.9 
-17,000 
-95 
Lung Cancer -4,100 -23 -30 -0.18 -4,100 -22 
Morbidity 
 Scenario 1 Scenario 2 Scenario 3 
Endpoint Incidence Value ($ millions) Incidence 
Value ($ 
millions) 
Incidence Value ($ millions) 
Acute 
Bronchitis 
-36,000 -2.1 -600 -35 -35,000 -2.1 
Acute 
Myocardial 
Infarction, 
Nonfatal 
-2,800 -140 -50 -2.2 -2,800 -140 
Asthma 
Exacerbation, 
Cough 
-8,100,000 -1,300 -140,000 -23 -8,000,000 -1,300 
Asthma 
Exacerbation, 
Shortness of 
Breath 
-610,000 -96 -11,000 -1.7 -600,000 -94 
Asthma 
Exacerbation, 
Wheeze 
-970,000 -152 -18,000 -2.7 -960,000 -150 
Chronic 
Bronchitis 
-17,000 -2,600 -380 -58 -17,000 -2,600 
Emergency 
Room Visits, 
Asthma 
-17,000 -5.3 -590 -180 -17,000 -5.2 
Hospital 
Admissions, 
All 
Cardiovascular 
-10,000 -260 -170 -4.3 -10,000 -260 
Hospital 
Admissions, 
All Respiratory 
-8,100 -170 -100 -2.1 -8,000 -170 
Hospital 
Admissions, 
-5,500 -110 -100 -2.0 -5,400 -110 
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Congestive 
Heart Failure 
Hospital 
Admissions, 
Dysrhythmia 
-1,500 -30 -30 -0.57 -1,500 -39 
Hospital 
Admissions, 
Ischemic Heart 
Disease 
-2,000 -66 -20 -0.75 -2,000 -65 
Hospital 
Admissions, 
Pneumonia 
-5,600 -100 -50 -0.87 -5,500 -100 
Lower 
Respiratory 
Symptoms 
-460,000 -7.1 -7,800 -0.12 -450,000 -7.0 
Minor 
Restricted 
Activity Days 
-18,000,000 -910 -410,000 -21 -18,000,000 -900 
Upper 
Respiratory 
Symptoms 
-670,000 -130 -12,000 -2.2 -660,000 -120 
Work Loss 
Days 
-3,100,000 -380 -70,000 -8.7 -3,000,000 -s380 
 
 
Section 3: Temperature Health Impact Assessment 
 
 
 We estimate 31,000 instances of cardiovascular mortality and 25,000 non-accidental 
mortality cases in 2025 relative to 2005 using BenMap. These estimates are similar to those of 
PM2.5 mortality in Scenario 1 (26,000), and are substantially higher than those of ozone 
respiratory mortality (2,400). Although our aim is to evaluate the influence of climate change on 
heat-related mortality, year-to-year climate variability may be responsible for a large portion of 
our estimated increase in mortality, due to our choice of especially cold (2002) and warm (2024) 
years.  
   
Table 17. The nationwide temperature mortality between 2005 and 2025. Non-accidental mortality includes all mortality types 
excluding those caused by traumatic incidents.   
Temperature Mortality 
Endpoint Start Age End Age Estimate 5th Percentile 95th Percentile 
Cardiovascular 0 99 +31,000 +18,000 +44,000 
  Non-Accidental 0 99 +25,000 +6,000 +43,000 
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Geographical Distribution of Temperature Mortality 
 
 
 As seen in Figure 9, the mortality due to temperature change is projected to be highest in 
densely populated urban centers such as Chicago, IL; Detroit, MI; Dallas-Fort Worth, TX; 
Pittsburg, PA; Washington, D.C; Boston, MA; and New York City, NY. Several key factors may 
account for this phenomenon, including more vulnerable individuals living in cities and the large 
general population of urban centers.  
 Another pattern that emerges in Figure 9 is that temperature mortality is confined mostly 
to the Eastern United States. The Pacific Northwest, California, and much of the western United 
States have low temperature-related mortality, especially when compared to those of the 
Midwest or Northeast and New England. A map of non-accidental temperature mortality can be 
found in Appendix G.  
Figure 9. Cardiovascular mortality due to temperature change at the county level. The majority of the increase in mortality is 
concentrated in highly populated urban areas, especially in the Midwest and Northeast.  
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Section 4: Temperature Economic Valuation 
 
 
 By using the economic valuation equations and standard mortality cost variables loaded 
in the BenMap program, we estimate the financial costs of temperature-related mortality in the 
United States. We estimate a $200 billion cost associated with the 31,000 excess cases of 
cardiovascular mortality annually and $160 billion due to the 25,000 cases of non-accidental 
mortality (Table 18.)  
 Our results demonstrate that the economic toll of temperature-related mortality is 
staggering, totaling hundreds of billions of dollars. High temperatures place strain on the 
economies of urban areas especially, as the heat island effect, vulnerable populations, and lack of 
air conditioning exacerbate hot summer temperatures. These findings suggest that the benefits of 
adaptation measures against rising temperatures may outweigh the costs.  
Table 18. Annual Economic valuation of the temperature-caused mortality in the United States.  
Temperature Economic Valuation 
Endpoint Incidence Valuation (billions of $) 
Cardiovascular +31,000 +200 
  Non-Accidental +25,000 +160 
 
Section 5: Total Economic Valuation 
 
 
 The future economic costs of ozone, fine particulate matter, and high temperature 
exposure number in the hundreds of billions of dollars. We estimate that these costs could 
amount to over $47 billion (Table 19) in the total change scenario. These increases in costs are 
due mainly to temperature mortality. Along with the underlying mortality and morbidity 
estimates, these economic values suggest that future changes in air pollution and high 
temperature may cause substantial damage to society.  
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All health endpoint groups (mortality, hospital admissions, emergency room visits, etc.) 
were accounted for in the total economic valuation. Various health endpoints were chosen as 
representatives of each endpoint, to avoid redundancy or double-counting. For example, the 
endpoints “All respiratory hospital admissions” and “All cardiovascular hospital admissions” 
were chosen to represent the totals of the different respiratory and cardiovascular hospital 
admissions, respectively.  
 The total ozone economic value was summed in similar fashion to the 2008 ozone RIA 
and includes the following endpoints: respiratory mortality, all respiratory hospital admissions, 
emergency room visits, restricted activity days, and lost days of school (EPA, 2008). The total 
economic valuation of PM2.5 is based on the 2012 PM2.5 RIA and includes the following 
endpoints: all-cause mortality, acute and chronic bronchitis, acute myocardial infarction, asthma 
exacerbation, emergency room visits, all respiratory and all cardiovascular hospital admissions, 
upper and lower respiratory symptoms, restricted activity days, and lost days of work (EPA, 
2012). Cardiovascular mortality was chosen to represent the economic total for temperature.  
 
Table 19. The economic value totals of the three air quality scenarios and one temperature scenario.  
Total Economic Valuation 
Pollutant Scenario 1 Scenario 2 Scenario 3 
Ozone -6.4 +4.5 -10.1 
PM2.5 -145.9 -2.2 -144.9 
Temperature 200 200 NA 
Total 47.7 202.3 -155 
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CHAPTER 4: DISCUSSION 
 
 
Future Temperature and Air Quality 
 
 
 Our results suggest a trend of increasing temperatures in the continental United States 
between 2005 and 2025. These rising temperatures have the potential to cause thousands of 
deaths and cost billions of dollars. 
 Ozone and particulate matter levels are projected to decrease across North 
America over the course of the 21st century in the RCP4.5 scenario (West et al., 2013, Fiore et 
al., 2012). Our analysis of an ozone concentration scenario simulating both emissions and 
meteorology suggests that ozone concentrations will increase slightly throughout a large portion 
of the country, including the central part of the nation (Midwest, Great Plains), while falling 
significantly along the East Coast and in the Southwest. Simultaneously, PM2.5 concentrations in 
this scenario demonstrate decreases in the Eastern and Central US, while increasing throughout 
the western part of the country. Fine particulate matter is also significantly less sensitive to 
changes in meteorology than is ozone, whereas both pollutants are heavily influenced by 
precursor emissions levels.  
The health impacts of air pollution follow this geographical pattern, with the largest 
reductions in morbidity and mortality occurring in cities and coastal regions and increases in 
rural areas and the central part of the country. Climate change and climate variability both 
influence these trends in air quality and temperature, although it is unclear how influential each 
factor might be. 
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Magnitude of Change and Comparison with Previous Studies 
 
 The main objective of this study is to estimate the changes in mortality of air pollution 
and heat in the same modeling simulation. Our results show decreasing air pollution-related 
mortality; 26,000 fewer cases of mortality due to PM2.5 and 2,400 fewer cases associated with 
ozone. We estimate heat-related mortality to increase by 31,000, leading to a net mortality 
increase of 2,600 associated with changes in these atmospheric phenomena in the combined 
emissions/climate scenario.  
 Previous studies have investigated air quality and temperature health impacts using 
BenMap, and have shown a range of results. Table 20 displays the findings of four related 
studies. Different assumptions and inputs were used in different studies, but comparisons 
between these studies and ours reveals a similar order of magnitude in changing mortality and 
morbidity rates.  
  Studies by Post et al., Tagaris et al., and Voorhees et a., investigated the health impacts 
of changes in either air quality or temperature between 2000 and 2050 and found a wide range of 
results (Table 20). The air quality-related mortality estimates from Tagaris et al., and Post et al., 
exhibit significant deviation from our estimates. Whereas our estimates of non-accidental 
temperature-related mortality coincide closely with those of Voorhees et al., our cardiovascular 
mortality estimates differ substantially from those of that study. The significant difference in 
results between our study and similar studies may be accounted for by the large difference in air 
quality and temperature modeling scenarios; our modeled scenario comprised a twenty year 
period whereas the related studies use a fifty year scenario comparison.  
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Table 20. Previous health impact studies of air pollution or temperature using BenMap.  
Study Pollutant(s) Subject Annual Results 
Fann et al., 2011 Ozone, PM2.5 
2005 anthropogenic vs 
natural air quality 
130,000 PM
2.5
 deaths, 
4,700 ozone deaths  
Tagaris et al., 2009 Ozone, PM2.5 
Climate change and air 
quality, 2000-2050 
4,000 PM
2.5
-related 
mortality, ozone 
mortality of 300 
Post et al., 2012 Ozone 
Climate change 2000-2050, 
sensitivity analysis 
Range of -600 to 2,500 
deaths due to ozone 
Voorhees et al., 
2011 
Temperature Climate change 2000-2050 
3,800 all-cause deaths, 
3,500 cardiovascular 
deaths, and 24,000 non-
accidental deaths  
 
 
Uncertainties and Limitations 
 
The air pollutant concentrations are calculated by computer models, which are subject to 
inherent assumptions by the modeler and limitations of computing power.  Only two years are 
compared in this study, and thus year-to-year climate variability is not accounted for. Our results 
may be more heavily determined by climate variability rather than climate change. Additionally, 
the time period used in our comparison comprises only twenty years, whereas many air quality 
and temperature projections compare longer time periods, which may identify a larger signal of 
change.  
We did not estimate particulate matter-related mortality for those under the age of thirty, 
due to the age cohort of the study from which the health impact function is derived (Krewski et 
al., 2009).  For this reason, our results of mortality attributable to PM2.5 may be significantly 
underestimated. Other health endpoints based on studies with limited age ranges may also have 
underestimated results.  
Whereas BenMap includes baseline mortality data projections for the year 2025, baseline 
morbidity data in this study do not include projections for future years. Because population and 
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baseline mortality projections for the year 2025 were used, projected changes in population and 
baseline incidence rates may exert significant influence on our results.  
 Modeled temperature data were taken from the WRF model, which BenMap was not 
designed to be used with. As with air pollutant concentrations, assumptions and uncertainties 
exist in modeling temperature levels. Health impact functions, beta coefficients and standard 
error values for temperature analysis had to be created in BenMap, along with the pollutant 
profile and metrics for temperature.  
In estimating PM2.5 changes, modeled PM2.5 was used directly, and not processed through 
the Speciated Modeled Attainment Test (SMAT) (Frank, 2006) used by EPA. SMAT is a 
procedure that entails the combination of quarterly mean estimates of the six major components 
of PM2.5 with a pollutant-specific relative reduction factor derived from model simulations, 
giving weighted concentrations for each component. These quarterly values are then averaged to 
produce annual mean concentrations of each component, which are summed to give annual 
concentrations of PM2.5.  The SMAT procedure allows for modeled PM data to be adjusted for 
observations before those data are used in other analyses. This process was not used in this study, 
as the modeled changes in PM2.5 were used directly from the CMAQ model outputs. Our PM2.5-
related health impacts might have differed had the SMAT procedure been used. 
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CHAPTER 5: CONCLUSION 
 
 
In this study, we analyze an air quality and temperature scenario in the continental United 
States for the year 2025 as compared to the baseline year of 2005. The Scenario 1-baseline 
comparison most closely reflects real-world conditions, as it includes simultaneous projections of 
emissions and meteorology.  
Our ozone-related health impact results include the following: respiratory mortality 
estimated at -2,400 (90% CI -1,100 to -3,700) in Scenario 1 (2025 emissions and meteorology) 
relative to the baseline, +1,700 (90% +730 to +2,600) in the Scenario 2 (climate change only) 
comparison, and -3,900 (90% CI -2,900 to -4,900) in Scenario 3 (emissions only.) Other notable 
health impacts of ozone exposure include thousands of fewer hospital admissions and emergency 
room visits, and millions fewer lost days of school.  
We estimate the change in all-cause mortality attributable to PM2.5 at -26,000 (90% -
19,000 to -32,000) in Scenario 1, -350 (90% CI -260 to -450) in the Scenario 2, and -25,000 
(90% CI -18,000 to -32,000) in Scenario 3 as compared to the baseline. In Scenario 1, PM2.5 is 
estimated to cause many thousands fewer hospital admissions, emergency room visits, and cases 
of bronchitis, as well as millions fewer restricted activity days and lost days of work. In the 
temperature health impact assessment, we estimate cardiovascular mortality to be +31,000 (90% 
CI +18,000 to +44,000). It is noteworthy that heat-related mortality increases significantly while 
mortality and morbidity due to air pollution decrease substantially in the combined 
climate/emissions simulation.  
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Our economic valuation of health impacts due to ozone, PM2.5, and temperature include 
billions of dollars annually in mortality-related costs, with the escalation in costs attributable 
heat-related mortality. We also show reductions of hundreds of millions of dollars associated 
with air pollution-related morbidity, with the exception of Scenario 2. The total economic cost of 
air pollution and temperature health impacts may be as high as 47 billion dollars when both 
emissions and meteorology are considered.  
  
These results demonstrate the importance of emissions mitigation and climate change 
adaptation measures, especially in sensitive areas. Mitigation of ozone and particulate matter 
precursors substantially reduce morbidity and mortality levels, and the mitigation of greenhouse 
gas emissions contribute to improved human health by limiting dangerous increases in 
temperature and air pollutant concentrations, specifically ozone. Adaptation measures are also 
supported by our findings, including enhanced public health monitoring and services, reductions 
in the urban heat island effect, and expanded access to air conditioning and cooling centers.  
A wide range of human health impacts may be limited through air pollution mitigation 
and climate change adaptation. The potential benefits to human and economic health in the 
United States achieved by controlling emissions and limiting global warming will be substantial 
and long-lasting.  
 
Future Work 
 
 In the future, this project can be built upon by addressing the issue of climate variability. 
Climate variability can be controlled for in two ways. First, selecting a longer scenario time 
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period, such as 2000 to 2050, allows for a larger influence of changing climate, a phenomenon 
that arises over long periods of time, and of changing emissions. Second, comparing multi-year 
averages instead of single years accounts for the variability between years.  
 Further work is needed to investigate the interaction of air pollutants and temperature on 
human health. Additional health endpoints, such as ozone-related COPD and respiratory 
infections, should also be investigated to gain a more comprehensive view of the health impacts 
of air pollution. Temperature-related morbidity can also benefit from further study by using the 
methodology used for temperature-related mortality in this research.   
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APPENDIX A: OZONE HEALTH IMPACT FUNCTIONS SPECIFICATIONS 
 
Endpoint 
Start 
Age 
End 
Age 
Beta Reference 
Emergency Room 
Visits, Asthma 
0 99 -0.001 
Wilson, A.M., C.P. Wake, T. Kelly et al. 2005. Air pollution 
and weather, and respiratory emergency room visits in two 
northern New England cities: an ecological time-series study. 
Environ Res. Vol. 97 (3): 312-21. 
HA, All Respiratory 0 1 0.008177 
Burnett, R.T., et al. Association between ozone and 
hospitalization for acute respiratory diseases in children less 
than 2 years of age. Am J Epidemiol, 2001. 153(5): p. 444-
52. 
HA, Chronic Lung 
Disease 
65 99 0.00196 
Moolgavkar, S.H., E.G. Luebeck, and E.L. Anderson. Air 
pollution and hospital admissions for respiratory causes in 
Minneapolis St. Paul and Birmingham. Epidemiology, 1997. 
8(4): p. 364-370. 
HA, Chronic Lung 
Disease (less 
Asthma) 
65 99 0.003424 
Schwartz, J. Air Pollution and Hospital Admissions For the 
Elderly in Detroit, Michigan. American Journal of 
Respiratory and Critical Care Medicine, 1994 150(3): p. 648-
655. 
HA, Pneumonia 65 99 0.002784 
Schwartz, J. PM(10) Ozone, and Hospital Admissions For 
the Elderly in Minneapolis St Paul, Minnesota. Archives of 
Environmental Health, 1994. 49(5): p. 366-374. 
Minor Restricted 
Activity Days 
18 64 0.002596 
Ostro, B.D. and S. Rothschild. Air Pollution and Acute 
Respiratory Morbidity – an Observational Study of Multiple 
Pollutants. Environ Res, 1989. 50(2): p. 238-247. 
Mortality, All Cause 0 99 0.001121 
Levy, J.I., S.M. Chemerynski, and J.A. Sarnat. Ozone 
exposure and mortality: an empiric bayes metaregression 
analysis. Epidemiology, 2005. 16(4): p. 458-68. 
Mortality, 
Cardiopulmonary 
0 99 0.000813 
Huang, Y., F. Dominici and M. L. Bell. 2005. Bayesian 
hierarchical distributed lag models for summer ozone 
exposure and cardio-respiratory mortality. Environmetrics. 
Vol. 16: 547–562. 
Mortality, Non-
Accidental 
0 99 0.000261 
Bell, M.L., et al. Ozone and short-term mortality in 95 US 
urban communities, 1987-2000. JAMA, 2004. 292(19): p. 
2372-8. 
Mortality, 
Respiratory 
30 99 0.004471 
Jerrett, Michael, Burnett, Richard T, Pope, Arden C, et al. 
2009. Long-Term Ozone Exposure and Mortality. New 
England Journal of Medicine. 
School Loss Days, 
All Cause 
5 17 0.007824 
Gilliland, F.D., K. Berhane, E.B. Rappaport, D.C. Thomas, 
E. Avol, W.J. Gauderman, S.J. London, H.G. Margolis, R. 
McConnell, K.T. Islam and J.M. Peters. 2001. The effects of 
ambient air pollution on school absenteeism due to 
respiratory illnesses. Epidemiology, 12(1), 43-54. 
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APPENDIX B: PM2.5 HEALTH IMPACT FUNCTIONS SPECIFICATIONS 
 
Endpoint 
Start 
Age 
End 
Age 
Beta Reference 
Acute Bronchitis 8 12 0.027212 
Dockery, D.W., J. Cunningham, A.I. Damokosh, L.M. 
Neas, J.D. Spengler, P. Koutrakis, J.H. Ware, M. 
Raizenne and F.E. Speizer. 1996. Health Effects of Acid 
Aerosols On North American Children - Respiratory 
Symptoms. Environmental Health Perspectives. Vol. 
Acute Myocardial 
Infarction, Nonfatal 
0 99 0.00225 
Zanobetti, A., M. Franklin and J. Schwartz. 2009. Fine 
particulate air pollution and its components in association 
with cause-specific emergency admissions. 
Environmental Health Vol. 8: 58-60. 
Asthma Exacerbation, 
Cough 
18 64 0.00741 
Ostro, B.D. and S. Rothschild. Air Pollution and Acute 
Respiratory Morbidity - an Observational Study of 
Multiple Pollutants. Environ Res, 1989. 50(2): p. 238-
247. 
Asthma Exacerbation, 
Shortness of Breath 
6 18 0.019062 
Mar, T. F., T. V. Larson, R. A. Stier, C. Claiborn and J. 
Q. Koenig. 2004. An analysis of the association between 
respiratory symptoms in subjects with asthma and daily 
air pollution in Spokane, Washington. Inhal Toxicol. Vol. 
16 (13): 809-15. 
Asthma Exacerbation, 
Wheeze 
6 18 0.002565 
Ostro, B., M. Lipsett, J. Mann, H. Braxton-Owens and M. 
White. 2001. Air pollution and exacerbation of asthma in 
African-American children in Los Angeles. 
Epidemiology. Vol. 12 (2): 200-8. 
Chronic Bronchitis 6 18 0.001942 
Ostro, B., M. Lipsett, J. Mann, H. Braxton-Owens and M. 
White. 2001. Air pollution and exacerbation of asthma in 
African-American children in Los Angeles. 
Epidemiology. Vol. 12 (2): 200-8. 
Emergency Room Visits, 
Asthma 
27 99 0.0137 
Abbey, D.E., B.E. Ostro, F. Petersen and R.J. Burchette. 
1995. Chronic Respiratory Symptoms Associated with 
Estimated Long-Term Ambient Concentrations of Fine 
Particulates Less Than 2.5 Microns in Aerodynamic 
Diameter (PM2.5) and Other Air Pollutants. J E 
Hospital Admissions, All 
Cardiovascular (less 
Myocardial Infarctions) 
0 99 0.005603 
Mar, T. F., J. Q. Koenig and J. Primomo. 2010. 
Associations between asthma emergency visits and 
particulate matter sources, including diesel emissions 
from stationary generators in Tacoma, Washington. Inhal 
Toxicol. Vol. 22 (6): 445-8.  
Hospital Admissions, All 
Respiratory 
65 99 0.00189 
Zanobetti, A., M. Franklin and J. Schwartz. 2009. Fine 
particulate air pollution and its components in association 
with cause-specific emergency admissions. 
Environmental Health Vol. 8: 58-60. 
Hospital Admissions, 
Congestive Heart Failure 
65 99 0.00207 
Zanobetti, A., M. Franklin and J. Schwartz. 2009. Fine 
particulate air pollution and its components in association 
with cause-specific emergency admissions. 
Environmental Health Vol. 8: 58-60. 
Hospital Admissions, 
Dysrhythmia 
0 17 0.002 
Babin, S. M., H. S. Burkom, et al. 2007. Pediatric patient 
asthma-related emergency department visits and 
admissions in Washington, DC, from 2001–2004, and 
associations with air quality, socio-economic status and 
age group. Environ Health 6: 9. 
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Hospital Admissions, 
Ischemic Heart Disease 
(less Myocardial 
Infarctions) 
65 99 0.00185 
Moolgavkar, S.H. Air Pollution and Daily Deaths and 
Hospital Admissions in Los Angeles and Cook Counties. 
In: Revised Analyses of Time-Series Studies of Air 
Pollution and Health. 2003, Health Effects Institute: 
Boston, MA. p. 183-198. 
Hospital Admissions, 
Pneumonia 
18 64 0.0022 
Moolgavkar, S.H. Air Pollution and Hospital Admissions 
for Chronic Obstructive Pulmonary Disease in Three 
Metropolitan Areas in the United States. Inhalation 
Toxicology, 2000. 12(Supplement 4): p. 75-90. 
Lower Respiratory 
Symptoms 
65 99 0.003979 
Ito, K. Associations of Particulate Matter Components 
with Daily Mortality and Morbidity in Detroit, Michigan. 
In: Revised Analyses of Time-Series Studies of Air 
Pollution and Health. 2003, Health Effects Institute: 
Boston, MA. p. 143-156. 
Minor Restricted 
Activity Days 
7 14 0.019012 
Schwartz, J. and L.M. Neas. 2000. Fine particles are more 
strongly associated than coarse particles with acute 
respiratory health effects in schoolchildren. 
Epidemiology. Vol. 11 (1): 6-10. 
Mortality, All Cause 30 99 0.005827 
Krewski D, Jerrett M, Burnett R, et al. 2009. Extended 
Follow-Up and Spatial analysis of the American Cancer 
Society Linking Particulate Air Pollution and Mortality. 
Health Effects Institute, Cambridge MA 
Mortality, Ischemic 
Heart Disease 
30 99 0.021511 
Krewski D, Jerrett M, Burnett R, et al. 2009. Extended 
Follow-Up and Spatial analysis of the American Cancer 
Society Linking Particulate Air Pollution and Mortality. 
Health Effects Institute, Cambridge MA 
Mortality, Lung Cancer 30 99 0.013103 
Krewski D, Jerrett M, Burnett R, et al. 2009. Extended 
Follow-Up and Spatial analysis of the American Cancer 
Society Linking Particulate Air Pollution and Mortality. 
Health Effects Institute, Cambridge MA 
Upper Respiratory 
Symptoms 
9 11 0.0036 
Pope, C.A., et al. Respiratory Health and Pm10 Pollution 
- a Daily Time Series Analysis. American Review of 
Respiratory Disease, 1991. 144(3): p. 668-674. 
Work Loss Days 18 64 0.0046 
Ostro, B.D. Air Pollution and Morbidity Revisited: A 
Specification Test. Journal of Environmental Economics 
and Management, 1987. 14: p. 87-98. 
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APPENDIX C: TEMPERATURE HEALTH IMPACT FUNCTION SPECIFICATIONS 
 
Temperature Health Impact Functions 
 
Endpoint 
Start 
Age 
End Age Beta Reference 
Cardiovascular 
Mortality 
0 99 0.0046248 
Basu, R.; Ostro, B. A multicounty analysis 
identifying the populations vulnerable to 
mortality associated with high ambient 
temperature in California. Am. J. Epidemiol. 
2008, 168 (6), 632 – 637. 
Non-Accidental 
Mortality 
0 99 0.003921 
Basu, R.; Ostro, B. A multicounty analysis 
identifying the populations vulnerable to 
mortality associated with high ambient 
temperature in California. Am. J. Epidemiol. 
2008, 168 (6), 632 – 637. 
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APPENDIX D: AIR QUALITY AND TEMPERATURE DELTA VALUE MAPS 
Ozone 
Figure 4. The ozone concentration (ppb) delta values in Scenario 1 compared to the baseline.  
 
 
Figure 5. The ozone concentration (ppb) delta values in the comparison of Scenario 2 against the baseline.  
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Figure 6. The ozone concentration (ppb) delta values in Scenario 3 as compared to the baseline.  
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Particulate Matter 
 
Figure 7. The PM2.5 concentration (µg/m3) delta values in the comparison of Scenario 1 to the baseline.  
 
 
Figure 8. The PM2.5 concentration (µg/m3) delta values in Scenario 2 relative to the baseline.  
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Figure 9. The PM2.5 concentration (µg/m3) delta values in Scenario 3 as compared to the baseline.  
 
 
Temperature 
 
Figure 10. The apparent temperature level delta values in degrees Kelvin, 2005-2025.  
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APPENDIX E: OZONE HEALTH IMPACT ASSESSMENT MAPS 
 
Figure 11. The change in county-level rates of emergency room visits attributable to ozone exposure in Scenario 1. Positive 
values designate decreasing morbidity.  
 
 
 
Figure 12. The change in the rate of lost days of school associated with ozone exposure in Scenario 1. 
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Figure 13. Emergency room visit rate changes from ozone exposure in Scenario 2. 
 
 
 
Figure 14. Changes in the rate of lost days of school due to ozone exposure in Scenario 2. 
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Figure 15 displays the change in ozone-caused emergency room visits in Scenario 3. 
 
 
Figure 16. Changes in the rate of lost days of school associated with ozone in Scenario 3. 
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APPENDIX F: PM2.5 HEALTH IMPACT ASSESSMENT MAPS 
 
Figure 17. The change in all respiratory hospital admissions rates at the county level from PM2.5 in Scenario 1. 
 
 
Figure 18. This map shows the change in lost days of work linked to PM2.5 exposure in Scenario 1 at the county-level. 
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Figure 19. The change in all respiratory hospital admissions due to fine particulate matter exposure in Scenario 2. 
 
 
Figure 20. The change in lost days of work in Scenario 2.  
 
 
 
 
 
 
59 
 
Figure 21. Change in all respiratory hospital admissions associated with fine particulate matter in Scenario 3. 
 
 
Figure 22. The change in PM2.5-related lost days of work from Scenario 3.  
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APPENDIX G: TEMPERATURE HEALTH IMPACT ASSESSMENT MAPS 
 
Figure 23. The trend of county-level heat-related non-accidental mortality in 2025 compared to 2005.  
 
  
61 
 
REFERENCES 
 
Anenberg, S. C., Horowitz, L. W., Tong, D. Q., & West, J. J. (2010). An estimate of the global 
burden of anthropogenic ozone and fine particulate matter on premature human mortality using 
atmospheric modeling. Environmental Health Perspectives, 118(9), 1189-1195.  
 
Bernard, S. M., Samet, J. M., Grambsch, A., Ebi, K. L., & Romieu, I. (2001). The potential 
impacts of climate variability and change on air pollution-related health effects in the United 
States. Environmental Health Perspectives, 109(Suppl 2), 199. 
Brauer, M., Amann, M., Burnett, R. T., Cohen, A., Dentener, F., Ezzati, M., ... & Thurston, G. D. 
(2012). Exposure assessment for estimation of the global burden of disease attributable to 
outdoor air pollution. Environmental Science & Technology, 46(2), 652-660. 
Centers for Disease Control and Prevention. (2006). CDC Wonder. US Department of Health and 
Human Services: Atlanta, GA; Available at http://wonder.cdc.gov/ 
EPA (2007). 2005 National Emission Inventory. Available at: http://www.epa.gov/ 
ttn/chief/net/2005inventory.html. 
 
EPA (2012). Inventory of Greenhouse Gas Emissions and Sinks: 1990-2011. United States 
Environmental Protection Agency. Washington, D.C. 
Fann, N., Lamson, A. D., Anenberg, S. C., Wesson, K., Risley, D., & Hubbell, B. J. (2012). 
Estimating the national public health burden associated with exposure to ambient PM2. 5 and 
ozone. Risk Analysis, 32(1), 81-95. 
 
Fiore A M et al (2012) Global air quality and climate. Chemical Society Review.41 6663–83. 
Forster, C., et al., (2001). Transport of boreal forest ﬁre emissions from Canada to Europe. J. 
Geophys. Res. 106, 22,887–22,906. 
Forster, P., et al., (2007). Changes in atmospheric constituents and in radiative forcing. 
Harlan, S. L., & Ruddell, D. M. (2011). Climate change and health in cities: impacts of heat and 
air pollution and potential co-benefits from mitigation and adaptation. Current Opinion in 
Environmental Sustainability, 3(3), 126-134. 
Solomon, S. (Ed.). (2007). Climate Change 2007: The Physical Science Basis. Contribution of 
Working Group I to the Fourth Assessment Report of the Intergovernmental Panel on Climate 
Change. Cambridge University Press, Cambridge, United Kingdom and New York, NY, USA. 
Jackson, J. E., Yost, M. G., Karr, C., Fitzpatrick, C., Lamb, B. K., Chung, S. H., ... & Fenske, R. 
A. (2010). Public health impacts of climate change in Washington State: projected mortality 
risks due to heat events and air pollution. Climatic change, 102(1-2), 159-186. 
Jacob, D. J., & Winner, D. A. (2009). Effect of climate change on air quality. Atmospheric 
Environment, 43(1), 51-63. 
62 
 
Jerrett, M., Burnett, R. T., Pope, C. A., Ito K., Thurston, G., Krewski, D., Shi, Y. L., Calle, E. 
and Thun, M. (2009) Long-term ozone exposure and mortality. New England Journal of 
Medicine. 360 1085–95 
Krewski, D., Calle, E. E., Thun, M. J., Beckerman, B., DeLuca, P., Finkelstein, N., . . . Thurston, 
G. (2009). Extended follow-up and spatial analysis of the American Cancer Society study linking 
particulate air pollution and mortality. Research Report (Health Effects Institute), (140), 5-114; 
discussion 115-36. 
 
Lam, Y. F., Fu, J. S., Wu, S., & Mickley, L. J. (2011). Impacts of future climate change and 
effects of biogenic emissions on surface ozone and particulate matter concentrations in the 
United States. Atmospheric Chemistry and Physics, 11(10), 4789-4806. 
Lepeule, J., Laden, F., Dockery, D., & Schwartz, J. (2012). Chronic exposure to fine particles 
and mortality: an extended follow-up of the Harvard Six Cities Study from 1974 to 2009. 
Environmental Health Perspectives, 120(7), 965. 
Lim, S. S., Vos, T., Flaxman, A. D., Danaei, G., Shibuya, K., Adair-Rohani, H., ... & Davis, A. 
(2013). A comparative risk assessment of burden of disease and injury attributable to 67 risk 
factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global 
Burden of Disease Study 2010. The lancet, 380(9859), 2224-2260. 
Luber, G., & McGeehin, M. (2008). Climate change and extreme heat events. American Journal 
of Preventive Medicine, 35(5), 429-435. doi:10.1016/j.amepre.2008.08.021 
Moss, R. H., Babiker, M., Brinkman, S., Calvo, E., Carter, T., Edmonds, J., ... & Zurek, M. 
(2008). Towards New Scenarios for Analysis of Emissions. In Climate Change, Impacts, and 
Response Strategies (IPCC Expert Meeting Report, IPCC, Geneva, 2008) 
Parry, M. L. (Ed.). (2007). Climate Change 2007: impacts, adaptation and vulnerability: 
contribution of Working Group II to the fourth assessment report of the Intergovernmental Panel 
on Climate Change (Vol. 4). Cambridge University Press. 
Pope III, C. A., Burnett, R. T., Turner, M. C., Cohen, A., Krewski, D., Jerrett, M., ... & Thun, M. 
J. (2011). Lung cancer and cardiovascular disease mortality associated with ambient air pollution 
and cigarette smoke: shape of the exposure–response relationships. Environmental health 
perspectives, 119(11), 1616. 
 
Post, E. S., Grambsch, A., Weaver, C., Morefield, P., Huang, J., Leung, L. Y., ... & Mahoney, H. 
(2012). Variation in estimated ozone-related health impacts of climate change due to modeling 
choices and assumptions. Environmental health perspectives, 120(11), 1559. 
 
Poumadere, M., Mays, C., Le Mer, S., & Blong, R. (2005). The 2003 heat wave in France: 
dangerous climate change here and now. Risk Analysis, 25(6), 1483-1494. 
Silva, R. A., West, J. J., Zhang, Y., Anenberg, S. C., Lamarque, J. F., Shindell, D. T., ... & Zeng, 
G. (2013). Global premature mortality due to anthropogenic outdoor air pollution and the 
contribution of past climate change. Environmental Research Letters, 8(3), 034005. 
63 
 
Stocker, T. F., Dahe, Q., & Plattner, G. K. (2013). Climate Change 2013: The Physical Science 
Basis. Working Group I Contribution to the Fifth Assessment Report of the Intergovernmental 
Panel on Climate Change.  
Tagaris, E., Liao, K., Delucia, A. J., Deck, L., Amar, P., & Russell, A. G. (2009). Potential 
impact of climate change on air pollution-related human health effects. Environmental Science & 
Technology, 43(13), 4979-4988.  
Tagaris, E., Liao, K. J., DeLucia, A. J., Deck, L., Amar, P., & Russell, A. G. (2010). Sensitivity 
of air pollution-induced premature mortality to precursor emissions under the influence of 
climate change. International journal of environmental research and public health, 7(5), 2222-
2237. 
 
Tagaris, E., Manomaiphiboon, K., Liao, K. J., Leung, L. R., Woo, J. H., He, S., ... & Russell, A. 
G. (2007). Impacts of global climate change and emissions on regional ozone and fine particulate 
matter concentrations over the United States. Journal of Geophysical Research: Atmospheres 
(1984–2012), 112(D14). 
Thomson, A. M., Calvin, K. V., Smith, S. J., Kyle, G. P., Volke, A., Patel, P., ... & Edmonds, J. 
A. (2011). RCP4. 5: a pathway for stabilization of radiative forcing by 2100. Climatic Change, 
109(1-2), 77-94. 
 
U.S. Environmental Protection Agency. (2008). Final Ozone NAAQS Regulatory Impact 
Analysis. EPA. Washington, DC.  
U.S. Environmental Protection Agency. (2012). Regulatory Impact Analysis for the Final 
Revisions to the National Ambient Air Quality Standards for Particulate Matter. EPA. 
Washington, DC.  
U.S. Environmental Protection Agency. (2013). Environmental Benefits Mapping and Analysis 
Program - Community Edition (Version 1.0.2). Research Triangle Park, NC. 
Voorhees, A. S., Fann, N., Fulcher, C., Dolwick, P., Hubbell, B., Bierwagen, B., & Morefield, P. 
(2011). Climate change-related temperature impacts on warm season heat mortality: A proof-of-
concept methodology using BenMAP. Environmental Science & Technology, 45(4), 1450-1457 
Weaver C. P. et al. (2009). A preliminary synthesis of modeled climate change impacts on US 
regional ozone concentrations Bulletin of Atmospheric Meteorology. Soc. 90 1843–63. 
West, J. J., Smith, S. J., Silva, R. A., Naik, V., Zhang, Y., Adelman, Z., ... & Lamarque, J. F. 
(2013). Co-benefits of mitigating global greenhouse gas emissions for future air quality and 
human health. Nature climate change, 3(10), 885-889. 
 
Wise, E.K., Comrie, A.C., (2005). Meteorologically adjusted urban air quality trends in the 
Southwestern United States. Atmospheric Environment. 39, 2969–2980. 
Woods and Poole Economics, Inc. (2012). Complete Economic and Demographic Data Source; 
Woods & Poole Economics, Inc.: Washington, DC.  
64 
 
Woody, M., Haeng Baek, B., Adelman, Z., Omary, M., Fat Lam, Y., Jason West, J., & 
Arunachalam, S. (2011). An assessment of Aviation’s contribution to current and future fine 
particulate matter in the United States. Atmospheric Environment, 45(20), 3424-3433. 
 
Zanobetti, A., & Schwartz, J. (2008). Temperature and mortality in nine US cities. 
Epidemiology, 19(4), 563-570. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
